Ram K. Selvaraju
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
[177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 24, 2025
Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer.
Journal: Nuclear medicine communications
Published: October 06, 2025
Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 03, 2025
Targeting mutant p53: Evaluation of novel anti-p53R175H monoclonal antibodies as diagnostic tools.
Journal: Scientific reports
Published: August 13, 2024
Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts.
Journal: Molecular cancer therapeutics
Published: June 29, 2024
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase.
Journal: Nuclear medicine and biology
Published: November 25, 2021
18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: August 04, 2020
Metabolically Active Brown Adipose Tissue Is Found in Adult Subjects with Type 1 Diabetes.
Journal: International journal of molecular sciences
Published: October 29, 2019
Synthesis and preclinical evaluation of the CRTH2 antagonist [11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass.
Journal: Nuclear medicine and biology
Published: December 09, 2018
Last Updated: 09/26/2026